article thumbnail

Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference?

Alpha Sense BI

Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. Additionally, unprofitable biopharma, aka most biotech companies, is expected to invest $1.1 Sign up for your free trial today.

Biotech 96
article thumbnail

Vaccine Development: What to Expect in 2023

Alpha Sense BI

Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.

Biotech 96
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BCG & Hello Tomorrow Track Innovation in Deep Tech Using NetBase Quid

Netbasequid

Want to know how many biotech companies have received private funding over the last ten years? Search for biotech companies receiving private funding over the last ten years. From here, the biotech world is your oyster. The Quid product encourages a deep dive into insights uncovered through the power of visualized data.

Biotech 98
article thumbnail

Venture Capital Trends and Outlook for 2024

Alpha Sense BI

Market Intelligence at Scale : GenAI has the potential to securely pair a company’s internal content with leading premium market content sources using proprietary large language models (LLMs) and genAI trained on both business and financial content. The renewable energy sub-sector is also seeing promising activity.

Capital 52
article thumbnail

Know where your competitors are conducting clinical trials!

Sedulo

Key Takeaways from the Assessment: While several insights were uncovered by analyzing trial clusters and the different IO drug modalities and sponsors, a few key takeaways from the data included: China emerging as innovation hub for IO therapies Smaller pharma/biotech conducting trials for emerging IO technologies Chinese and US small pharma/biotech (..)

Biotech 52
article thumbnail

The Evolution of AI in Asset Management

Alpha Sense BI

Research shows that the AI in asset management market will grow at a staggering 34% CAGR through 2027. The time is now to invest in a market intelligence platform with AI search capabilities, so you can speed up your research and outperform the market. Artificial intelligence is the only way to do it.

article thumbnail

What to Know About Medicare Drug Price Negotiations

Alpha Sense BI

The 10 initial drugs were chosen based on certain criteria set out by Medicare: they must be sold in pharmacies, not have substantial generic competition , and have been on the market for at least nine to 13 years for more complex biotech drugs. That’s why more professionals are turning to market intelligence solutions like AlphaSense.